Lavaca Capital’s Organon & Co OGN Stock Holding History

Lavaca Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$910	Buy	152 +97	+176%	+$730	﹤0.01%	280
2025 Q4	$394	Hold	55	–	–	﹤0.01%	282
2025 Q3	$587	Hold	55	–	–	﹤0.01%	265
2025 Q2	$532	Hold	55	–	–	﹤0.01%	263
2025 Q1	$819	Hold	55	–	–	﹤0.01%	242
2024 Q4	$821	Buy	+55	New	+$896	﹤0.01%	298
2022 Q1	–	Sell	-9,204	Closed	-$280K	–	197
2021 Q4	$280K	Sell	9,204 -118	-1%	-$3.84K	0.04%	139
2021 Q3	$306K	Sell	9,322 -1,478	-14%	-$47.3K	0.03%	128
2021 Q2	$327K	Buy	+10,800	New	+$356K	0.03%	122

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Lavaca Capital's OGN Position: Q1 2026 in Review

Lavaca Capital increased its Organon & Co (OGN) stake by 176% in Q1 2026, buying an estimated $730 and bringing the position to 152 shares worth $910. The position accounts for ﹤0.01% of the portfolio, ranked #280.

Lavaca Capital first reported a position in OGN in Q2 2021 and has held it in 9 quarters since. The position peaked at $327K in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

Lavaca Capital held 152 shares of Organon & Co worth $910 as of Q1 2026.
Lavaca Capital bought 97 Organon & Co shares in Q1 2026, an estimated $730.
Organon & Co made up ﹤0.01% of Lavaca Capital's portfolio in Q1 2026, its #280 holding.
Lavaca Capital first reported a position in Organon & Co in Q2 2021 and has held it in 9 quarters since.
Lavaca Capital's Organon & Co position peaked at $327K in Q2 2021.
603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Lavaca Capital's 13F filing for Q1 2026, filed 13 May 2026.